Congress locks in NIH research funding, bars agency from killing grants for policy shifts

What it does

This bill requires the NIH to immediately release and fully fund all existing grant agreements and pay pending reimbursement requests, while prohibiting the agency from terminating active research grants. Going forward, new NIH grants must include termination clauses that allow cancellation only for material breach, changed circumstances, or mutual agreement—with 90 days' notice and mandatory renegotiation attempts. The bill explicitly bars the NIH from terminating grants simply because they no longer align with agency priorities or program goals.

Why we flagged it

The bill's core function is to shield active NIH research grants from termination on grounds of changed agency priorities, ensuring continuity of federally funded scientific work. It is fundamentally a constraint on executive discretion in grant administration, not a new spending authorization.

What the text implies

• The bill may constrain the NIH Director's ability to reallocate resources in response to emerging public health crises or scientific breakthroughs that shift research priorities.
• By prohibiting termination for 'no longer effectuating program goals,' the bill could lock the agency into funding research that becomes scientifically obsolete or misaligned with evidence-based priorities.
• The 90-day notice and mandatory renegotiation requirement may create administrative burden and delay necessary course corrections in grant portfolios.
• Existing grants frozen under this bill may include projects initiated under prior administrations with different policy objectives, potentially creating tension between statutory mandate and current agency direction.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill protects ongoing scientific research from arbitrary termination by agency leadership, ensuring that researchers and institutions can complete funded work without fear of sudden defunding based on political or administrative shifts. This preserves the integrity of the peer-reviewed grant process and protects public investment in research that has already been approved and begun.

Who stands to gain

• research institutions (universities, medical centers, non-profit research organizations)
• individual researchers and research teams with active NIH grants

Named in the bill

National Institutes of Health (NIH), Secretary of Health and Human Services (SecHHS), NIH Director, Title 2, Code of Federal Regulations, Section 200.340

Where it stands

62 cosponsors: 62 Democrats.

• Jun 12, 2025 — Introduced · Congress.gov: “Introduced in House”
• Jun 12, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.